| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,694 |
20,696 |
$1.23M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,004 |
20,797 |
$920K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
4,317 |
3,755 |
$335K |
| 99397 |
|
2,532 |
2,333 |
$158K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,733 |
1,496 |
$145K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,689 |
2,886 |
$74K |
| 99233 |
Prolong inpt eval add15 m |
1,981 |
556 |
$55K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
538 |
374 |
$42K |
| 92552 |
|
2,084 |
1,472 |
$34K |
| 90662 |
|
1,237 |
1,015 |
$33K |
| 93000 |
|
1,634 |
1,354 |
$26K |
| 99386 |
|
243 |
141 |
$23K |
| 0240U |
|
207 |
196 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,625 |
1,197 |
$19K |
| 0012A |
|
583 |
568 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
246 |
151 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,106 |
2,889 |
$15K |
| 90686 |
|
993 |
623 |
$15K |
| 99223 |
Prolong inpt eval add15 m |
207 |
184 |
$14K |
| 0011A |
|
645 |
632 |
$12K |
| 99173 |
|
1,871 |
1,398 |
$11K |
| 99215 |
Prolong outpt/office vis |
264 |
166 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
56 |
54 |
$7K |
| 90688 |
|
475 |
344 |
$7K |
| 99385 |
|
64 |
45 |
$7K |
| 0064A |
|
215 |
197 |
$6K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
945 |
900 |
$6K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,533 |
969 |
$5K |
| 90732 |
|
152 |
134 |
$4K |
| G0247 |
Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails |
520 |
446 |
$4K |
| G0246 |
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education |
441 |
380 |
$3K |
| 69210 |
|
183 |
176 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
110 |
102 |
$2K |
| 99306 |
Prolong nursin fac eval 15m |
98 |
79 |
$2K |
| 0134A |
|
64 |
56 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,660 |
1,841 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
36 |
31 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
123 |
62 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
59 |
55 |
$1K |
| 81003 |
|
1,350 |
1,147 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
5,661 |
5,158 |
$1K |
| 20610 |
|
206 |
111 |
$1K |
| 83014 |
|
165 |
98 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,456 |
1,380 |
$1K |
| 0013A |
|
27 |
27 |
$750.68 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
222 |
151 |
$711.88 |
| 80061 |
Lipid panel |
1,450 |
1,388 |
$513.25 |
| 90670 |
|
91 |
91 |
$501.40 |
| G0008 |
Administration of influenza virus vaccine |
549 |
505 |
$499.84 |
| 94060 |
|
24 |
12 |
$464.17 |
| 0002A |
|
13 |
13 |
$445.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
56 |
25 |
$406.00 |
| 81001 |
|
1,002 |
934 |
$371.03 |
| 90649 |
|
57 |
26 |
$352.00 |
| 90672 |
|
44 |
43 |
$322.56 |
| 85610 |
|
170 |
91 |
$263.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,236 |
744 |
$213.75 |
| 90734 |
|
23 |
13 |
$147.20 |
| 82274 |
|
48 |
41 |
$140.00 |
| 90620 |
|
21 |
13 |
$128.00 |
| 82962 |
|
1,276 |
1,227 |
$108.26 |
| 82044 |
|
1,223 |
1,185 |
$96.15 |
| 64418 |
|
23 |
13 |
$73.44 |
| 64445 |
|
48 |
38 |
$73.39 |
| 36410 |
|
12 |
12 |
$70.13 |
| G0009 |
Administration of pneumococcal vaccine |
88 |
85 |
$56.40 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
589 |
340 |
$32.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
14 |
14 |
$12.50 |
| 90461 |
|
145 |
66 |
$12.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
12 |
$7.50 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
166 |
152 |
$1.67 |
| 64413 |
|
23 |
12 |
$0.14 |
| 3074F |
|
86 |
76 |
$0.00 |
| 91301 |
|
571 |
554 |
$0.00 |
| 91306 |
|
35 |
32 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
51 |
42 |
$0.00 |
| 99443 |
|
27 |
18 |
$0.00 |
| 99442 |
|
106 |
69 |
$0.00 |
| A4550 |
Surgical trays |
940 |
795 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
14 |
14 |
$0.00 |
| 3078F |
|
83 |
73 |
$0.00 |
| 91300 |
|
33 |
31 |
$0.00 |